Implementation Documentation and Process Assessment of the PharmNet Intervention: Observational Report

Area of Science:

• Public Health
• Pharmacy Practice
• Implementation Science

Background:

• The US faces an ongoing opioid overdose crisis, with over 100,000 annual deaths.
• Harm reduction strategies, including naloxone (opioid overdose reversal drug) access, are crucial.
• Community pharmacies are positioned to improve naloxone access and education due to their accessibility and pharmacists' expertise.

Purpose of the Study:

• To pilot the PharmNet intervention, which integrates naloxone distribution, awareness, and referrals in community pharmacies.
• To conduct a pilot randomized controlled trial of PharmNet in seven pharmacies.
• To transparently report available data and discuss trial barriers due to incomplete data collection.

Main Methods:

• An in-depth implementation study assessment.
• Reporting available observational data from the pilot trial.
• Discussing implementation considerations for independent community pharmacies.

Main Results:

• Resource disparities between independent and chain pharmacies impact intervention implementation.
• High staff demands can hinder intervention success, even with supportive leadership.
• Leadership support is crucial but may not be sufficient without adequate resources.

Conclusions:

• Independent community pharmacies may need enhanced support for implementing new interventions.
• Further implementation science research is necessary, specifically for independent pharmacies.
• Transparency in reporting all data, even from incomplete trials, is vital to avoid publication bias.